Key Takeaways
- • Massachusetts Governor Maura Healey signed the Healthcare Private Equity Reporting Act into law on January 8, 2025, establishing mandatory financial disclosure and ownership reporting requirements for private equity firms, REITs, and management services organizations (MSOs) operating in the state's healthcare sector.
- • The law mandates expanded annual reporting on debt levels, executive compensation, lobbying expenditures, and political spending for healthcare facilities owned or controlled by private equity investors, significantly broadening the state's regulatory oversight framework.
- • Private equity activity in Massachusetts concentrates heavily in behavioral health, home health and hospice, and dentistry, making these sectors subject to heightened scrutiny under the new disclosure regime.
- • The Massachusetts statute is narrower in scope than a California vetoed bill, which would have granted the state attorney general authority to block transactions; the Massachusetts law instead focuses on transaction-based reporting, annual disclosures, and testimony requirements for the Health Policy Commission's hearings.
- • Portfolio companies with Massachusetts healthcare operations must immediately review the law's definitions to determine applicability, particularly MSOs and private equity-backed platforms that may trigger reporting obligations.
Summary
Massachusetts has enacted comprehensive legislation designed to increase regulatory oversight of private equity investments in healthcare. Governor Maura Healey signed the Healthcare Private Equity Reporting Act on January 8, 2025, establishing a new disclosure framework that applies to private equity firms, real estate investment trusts (REITs), and management services organizations operating within the state's healthcare system.
The law expands existing provider financial and ownership reporting requirements by mandating that healthcare facilities disclose information specifically related to private equity ownership structures, debt levels, executive compensation, lobbying activities, and political spending. These expanded disclosure obligations represent a meaningful shift toward transparency in an industry where private equity investment activity has intensified across multiple segments.
According to healthcare transactions counsel John Saran, the Massachusetts statute differs materially from a more aggressive California bill that was vetoed because it would have granted the state attorney general authority to block private equity transactions outright. The Massachusetts approach takes a more measured regulatory stance, instead emphasizing transaction-based reporting, annual financial disclosures, and the requirement that affected entities provide testimony before the state's Health Policy Commission during its annual hearings. This framework balances regulatory oversight with industry flexibility.
Private equity investment in Massachusetts healthcare concentrates particularly in behavioral health services, home health and hospice operations, and dentistry. Firms operating in these sectors should anticipate heightened disclosure requirements. Saran advised that private equity sponsors review portfolio company structures carefully, particularly those involving MSOs, to determine whether the new law's definitions and thresholds trigger reporting obligations. The compliance framework applies not only to direct healthcare providers but also to management services organizations that control or operate healthcare businesses within Massachusetts.
The new law reflects growing state-level concern about private equity's impact on patient care, healthcare costs, and service accessibility. By establishing mandatory financial and ownership transparency, Massachusetts joins other states in tightening regulatory scrutiny of private equity healthcare transactions, though it stops short of transaction-blocking authority.
The law expands existing provider financial and ownership reporting requirements by mandating that healthcare facilities disclose information specifically related to private equity ownership structures, debt levels, executive compensation, lobbying activities, and political spending. These expanded disclosure obligations represent a meaningful shift toward transparency in an industry where private equity investment activity has intensified across multiple segments.
According to healthcare transactions counsel John Saran, the Massachusetts statute differs materially from a more aggressive California bill that was vetoed because it would have granted the state attorney general authority to block private equity transactions outright. The Massachusetts approach takes a more measured regulatory stance, instead emphasizing transaction-based reporting, annual financial disclosures, and the requirement that affected entities provide testimony before the state's Health Policy Commission during its annual hearings. This framework balances regulatory oversight with industry flexibility.
Private equity investment in Massachusetts healthcare concentrates particularly in behavioral health services, home health and hospice operations, and dentistry. Firms operating in these sectors should anticipate heightened disclosure requirements. Saran advised that private equity sponsors review portfolio company structures carefully, particularly those involving MSOs, to determine whether the new law's definitions and thresholds trigger reporting obligations. The compliance framework applies not only to direct healthcare providers but also to management services organizations that control or operate healthcare businesses within Massachusetts.
The new law reflects growing state-level concern about private equity's impact on patient care, healthcare costs, and service accessibility. By establishing mandatory financial and ownership transparency, Massachusetts joins other states in tightening regulatory scrutiny of private equity healthcare transactions, though it stops short of transaction-blocking authority.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.